A competitive radioimmunoassay for the quantitative determination of glycated haemoglobin was developed. The antiserum, obtained by immunizing guinea pigs with reduced glycated human albumin, was capable of identiffing and quantitating the glucitollysine residues of glycated Hb after reduction with sodium borohydride. To simplify the sample preparation we introduced trichloroacetic acid precipitation to remove unreacted sodium borohydride instead of using dialysis or gel filtration. Using this procedure, our radioimmunoassay became relatively simple and provided satisfactory within-and between-run (1.3-2.8% and 1.9-5.4% coefficient of variation, respectively). The radioimmunoassay method was compared to the measurement of HbA~c by high performance liquid chromatography which is the most widely used method for quantitating glycated Hb. For this purpose glycated Hb was measured in normal glucose tolerance, impaired glucose tolerance, and diabetes mellitus groups based on WHO criteria. Both assays were able to discriminate between the normal and diabetic groups. In addition, while the determination of glycated Hb by the radioimmunoassay method was able to clearly discriminate between the normal and impaired glucose tolerance groups, the determination of HbA~c by the high performance liquid chromatography method failed to discriminate between these two groups. Moreover, 15 of the 20 impaired glucose tolerance patients exceeded the upper normal range (mean normal values + 2 SD) in radioimmunoassay. But all 20 patients with impaired glucose tolerance were within the upper normal range in HbAic values.
Glycated Hb is being used with increasing frequency to monitor long-term blood glucose control in diabetes mellitus [1] [2] [3] [4] [5] . The test of glycated Hb provides an accurate index of the mean concentration of blood glucose during the preceding two or three months, complementing more traditional measures of glucose control, such as glucose testing in urine and blood. A variety of methods have been described for the determination of glycated Hb, but many of them have serious pitfalls [6, 7] . The clinical utility of glycated Hb measurement will not achieve its full potential until appropriate references, standards, and degrees of accuracy and precision of these measurements are agreed upon.
HbAlc is identical to HbA0 except that in HbAlc glucose is linked to the amino-terminal valine residue of the chain [8] . Modification of Hb with glucose confers a change in charge of the Hb molecule. Most methods for quantitating glycated Hb utilize this charge difference to separate the HbAic from HbA0 by ion-exchange chromatography or high performance liquid chromatography (HPLC) [7] . The amount of HbAlc is then expressed as a percentage of total Hb. Glucose can also condense with the e-amino groups of lysine residues, and the amount of Hb modified at these sites, which is increased in erythrocytes from diabetic patients [9] , is not always quantitatable by ion-exchange chromatography or HPLC.
We recently reported an enzyme-linked immunosorbent assay (ELISA) for detecting glycated serum proteins and a radioimmunoassay (RIA) for glycated serum albumin using an antiserum which was obtained by immunizing guinea pigs with reduced glycated human albumin [10, 11] . This antiserum contained antibodies which recognize glucitollysine epitopes in not only reduced glycated albumin and glycated plasma protein but also reduced glycated Hb. In this paper, we developed an RIA for glycated Hb using the antiserum 
Materials and methods

Reagents
Human serum albumin (HSA), human haemoglobin, CBZ-L-lysine, sodium borohydride (NaBH4) and bovine gamma globulin (G-5009) were obtained from Sigma Chemical Co. (St. Louis, Mo., USA). Bovine serum albumin (BSA,A-6003) was from Calbiochem Behring Co. (La Jolla, Calif., USA). Bio-Rex 70 and Affi-Gel 15 were from Bio-Rad Laboratories (Richmond, Calif., USA). Glyco-Gel B was from Pierce Chemical Co. (Rockford, Ill., USA). The 125I-radioiodination system was from New England Nuclear (Boston, Mass., USA). All other reagents were of the highest grade commercially available.
Preparation of glycated HSA, glycated Hb and glucitollysine
Reduced glycated HSA, reduced glycated Hb, non-reduced nonglycated HSA and non-reduced non-glycated Hb were prepared as described previously [10] . The extent of glycation of each sample was assessed by amino acid analysis as described by Traeb et al. [12] . The percentage of lysine residue glycation was 62% in reduced glycated HSA and 35% in the reduced glycated Hb. Glucitollysine was synthesized by the method of Trfieb et al. [12] . Glucitolvaline was synthesized by the method of Schwarz and Gray [13] .
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Immunization and preparation of antiserum to glucitollysine
Male guinea pigs were immunized with reduced glycated HSA as described previously [10] . To remove cross-reactivity with native HSA, i ml of the immunized guinea pig serum was purified on an AffiGel 15 column coupled to native HSA, eluted with 0.1 mol/l sodium phosphate buffer, pH 8.0, and stored at -70~
RadiolabeUing of liSA
Reduced glycated HSA and native HSA were iodinated by solidphase lactoperoxidase using radioiodination system [11] . The free iodide was separated from the labelled protein by chromatography on Sephadex G-25, PD 10. The specific activities of the labelled proteins were about 5000 cpm/ng.
Chromatography on Bio-Rex 70
Erythrocyte haemolysates were prepared after overnight 0.9% NaC1 incubation as described by Nathan et al.
[t4]. The haemolysates from a diabetic patient and a normal subject were then analysed on a Bio-Rex 70 column (1 x 30 cm) according to the method of Abraham et al. [15] .
Subjects and sample preparation
Following a 75 g oral glucose tolerance test, subjects were classified as having normal glucose tolerance (N)(n = 30, age range 18-76 years), diabetes mellitns (n = 30, 36-75 years), and impaired glucose tolerance (IGT)(n = 20, 40-76 years) according to WHO criteria [16] . Whole blood was collected in EDTA and centrifuged at 4~ 1500g, for 10 rain. Erythrocytes were washed three times with isotonic saline (0.9%), then diluted 1:20, and incubated overnight at 22~ to remove the labile aldimine fraction. After centrifugation at 4~ 1500g, for 10 min, the saline supernatant was removed and the erythrocytes were haemolyzed in 3 volume of distilled-deionized water and glycolipids were extracted with 3 volume of toluene. Separation of the haemolysate from toluene, glycolipids, and cell ghosts was accomplished by centrifugation at 1500g for 30 rain. An aliquot of each sample was reduced at 37~ for 30 rain with 50 retool/1 NaBH4. To remove unreacted NaBH4 and to stop the reduction, glycated Hb was precipitated by addition of ice-cold trichloroacetic acid (TCA, 6% final concentration), followed by centrifugation at 4~ 3000g, for 30 rain. The superuatant was discarded by aspiration and the sedimented protein dissolved in 0.05 N NaOH (TCA-NaOH treatment). The pH of this solution was adjusted to pH 7.4 using 0.2 mol/1 potassium phosphate-NaOH buffer. Reduced glycated Hb, appropriately diluted was also prepared by exhaustive dialysis against phosphate-buffered saline, pH 7.2 after NaBH4 reduction instead of TCA-N&OH treatment as described above.
Assay of glycated Hb
Test samples (100 gl) which were reduced with NaBH4 and treated with TCA-NaOH as mentioned before were incubated with 200 gl of 0.2 tool/1 potassium phosphate-NaOH buffer, pH 7.4 containing 0.25% BSA, 100 gl of antiserum [final dilution 1:500 at 50% inhibition (B/B0)], and 100 gl of 125I-labelled reduced glycated HSA, diluted to about 20,000 cpm, in polystyrene tubes for 24 h at 4~ After the incubation, bound tracer was precipitated by adding 10 gl (1 nag) of bovine gamma globulin and 500 gl of ice-cold 25% polyethylene glycol 6000 containing 0.1% Tween 20 and centrifuging at 3000 rev/min for 45 min at 4~ The radioactivity of the precipitate was counted in an LKB 1282 gamma counter. Glucitollysine at 0.005-5 nmol/100 gl was used as the standard. The Hb protein concentrations were determined according to Lowry et al. [18] . 
Hb A lc determination by HP L C
Determination of HbAlc was performed using HPLC, AUTO A1C (Kyoto Daiich Kagaku Co., Kyoto, Japan). The samples for the HPLC were prepared by using 0.9% NaC1 incubation to remove the labile aldimine fraction as mentioned before. The HPLC column used was the same one during all sample measurements. In this HPLC method, within-run precision (coefficient of variation, CV) was 5.5%, and between-run precision was 7.2%.
Statistical analysis
Statistical significance was analysed by the Student's t-test.
Results
Specificity of antiserum
The characterization of the antiserum was studied in a competitive RIA in our previous paper [10, 11] . The antiserum recognized glucitollysine. However, lysine, valine, mannitol and sorbitol were not recognized even when added in a large excess. Glucitolvaline was less than 1% cross-reactive when compared with glucitollysine. Reduced glycated Hb which was prepared from a diabetic patient was also recognized, and the shape of the inhibition curve was parallel with glucitollysine ( Fig. 1) . Non-reduced glycated Hb was not recognized even when added in a large excess. The binding of ~25I-labelled native human albumin and ~2~I-labelied non-reduced glycated HSA to the antiserum were less than 1% of the total amount (data not shown). These results indicated that cross-reactivity to native HSA was eliminated from the antiserum preparation and that the dominant epitope recognized by the antiserum was identified as glucitollysine; the reduced hexose alcohol form of glucose conjugated to the e-amino group of lysine. The antiserum was capable of identifying and quantitating glucitollysine residues on Hb after reduction with NaBH4.
For sample preparation we introduced TCA-NaOH treatment. Glucitollysine has been thought to be stable against acid like TCA [12, 19] . In order to make sure of the z. Makita et al.: Radioimmunoassay for glycated Hb stability of glucitollysine against 0.05 N NaOH we compared the effect of treatment with 0.05 N NaOH on a standard curve of glucitollysine, and we found no discernible difference between glucitollysine standards treated or not treated with NaOH (data not shown).
Discrepancies of estimated reduced glycated Hb valued by RIA with or without TCA-NaOH treatment
To investigate the effect of TCA-NaOH treatment, we assayed samples from two normal subjects and two diabetic patients, using the TCA-NaOH treatment method and the dialysis method after reduction of the samples ( Table 1) . The values using our TCA-NaOH method were more than 20-fold higher than the values using the dialysis method. Therefore, it is possible that TCA-NaOH treatment denatured Hb, and exposed hidden glucitollysine epitopes.
Linearity and precision of RIA
To assess the linear range, we prepared a series of six solutions which were obtained from the glycated Hb fraction by using a Glyco-GelB boronate affinity chromatography. All the samples were analysed four times by the RIA in different analytical batches (Fig.2) . The plot of values was linear from 0.1 to as high as 6 nmol glucitollysine. Therefore, all samples were measured in this region.
Within-run precision (CV) assessed by five analyses of three specimens and between-run precision assessed by five analyses of three specimens, in separate analytical runs, over a three-week period was as shown in Table 2 .
Bio-Rex 70 chromatographic fractionation of lib
In order to elucidate the localization of glucitollysine, we assayed all Bio-Rex 70 chromatographic fractions by our RIA. The chromatograms of Hbs from a normal subject and a diabetic subject are shown respectively in Figures 3  and 4 . A large amount of glucitollysine was incorporated into the leading edge of the major Hb components (HbA0) as reported by Bunn et al. [8] . Furthermore, it was clearly shown that the HbAla + b and HbAlc peaks from the normal and diabetic subjects contained glucitollysine. It was therefore confirmed that HbAlc is glycated not only at the [3-amino terminus but also at the lysine e-amino groups. 
Comparison of glycated Hb by RIA with HPLC
The results of assays for glycated Hb, carried out on the N, IGT and diabetic subjects, are presented in Figure 5 . The mean glycated Hb levels by RIA were 3.3 + 0.4 nmol glucitollysine/mgHb (mean + SD) in N, 4.7 + 0.5 in IGT and 14.4 + 7.5 in the diabetic group. The differences between the three groups were highly significant (p < 0.001).
On the other hand, the mean HbAlc levels by HPLC were 
Discussion
It has been generally accepted that the level of glycated Hb is a clinically useful measure of the average long-term glycaemic control in a diabetic patient. While the development of a quantitative methodology for the measurement of glycated Hb has been extensively carried out, there is still a need for better methods of measurement with appropriate references and standards with which accuracy and precision can be maintained. Recently, the National Diabetes Data Group in the United States has concluded that a major problem with all methods is that there are no agreed upon references and standards [6] . The RIA method presented in this report has the advantage of using glucitollysine which is chemically stable. Shapiro et al. found that sites of Hb glycation were different in vitro and in vivo [9] , so if glycated Hb was synthesized in vitro as a standard, it is chemically different from Hb glycated in vivo. On the other hand, glucitollysine was easily synthesized and was resistant to acidic and alkaline conditions [12, 19] . Since our RIA method used glucitollysine as a standard substance, this method has a chemically defined and stable reference standard.
In the sample preparation, it was necessary to reduce glycated Hb. After reduction, dialysis or gel filtration was generally used to stop the reduction and to remove unreacted NaBH4 [8, 20] . Since this is too time consuming for routine use we introduced the TCA-NaOH treatment after reduction as has been described previously [10] . By using the TCA-NaOH treatment, the assay was relatively simple. Moreover, the TCA-NaOH treatment seemed to have another advantage in that it offered greater sensitivity ( Table 1) . A possible explanation for this increased sensitivity has been reported in a study of murine monoclonal antibodies recognizing glucitollysine [20] . Utilizing this monoclonal antibody, the levels of glucitollysine quantitated were lower than previous estimates of the amount of glucose bound to total plasma proteins and it was though that the presence of hidden glucitollysine epitopes not accessible to the antibodies could account for the difference. As shown in Table 1 , the values determined by TCANaOH treatment were about 25 times higher than those by dialysis. The amount of glucose assayed RIA as bound to Z. Makita et al.: Radioimmunoassay for glycated Hb Hb in TCA-NaOH treated samples was similar to previous estimates by the HPLC analysis of furosine, a specific quantitation of e-amino group lysine-bound glucose in Hb [21, 22] . Moreover, the synthesized reduced glycated Hb contained 35% of the lysine residues. Thus, 15 moles of 44 moles of lysine residues were glycated as determined by amino acid analysis which is equivalent to about 200 nmol glucitollysine/mgHb. This value was similar to the 178 nmol glucitollysine/mgHb which was measured using the RIA with TCA-NaOH treatment. By contrast, the dialysis method revealed a far lower value of 7.0 nmol glucitollysine/mgHb. Thus, it is plausible that the increased values found following TCA-NaOH treatment in comparison with the dialysis method for sample preparation is a consequence of the unfolding of the Hb molecule, thereby exposing the hidden glucitollysine epitopes.
It has been shown previously that glucose is conjugated to the e-amino group of lysine of Hb which exists in the HbA0 [8, 21] . We are able to clearly demonstrate that glucose conjugated to the e-amino group of Hb exists not only in the HbA0 but also in the HbAlc (Figs. 3 and 4) .
The diagnostic value of the RIA method and the HPLC method was compared in the N, IGT, and diabetes groups. HbA~c as determined by HPLC could clearly separate a group of N from a group of diabetic patients, but could not separate a group of N from a group of IGT. On the other hand, by the RIA method there was a significant difference between the groups of N and IGT. Moreover, all of the 20 IGT patients were within the upper normal range for I-IbAlc by the HPLC method, but 15 of the 20 IGT patients exceeded the upper normal range for our RIA method. Thus the RIA method might be able to be used to detect IGT patients in a mass screening test.
A quantitative ELISA for glycated serum albumin by using the same antiserum [10] was recently developed in our laboratory and the RIA method seems to be applicable to quantitate any kind of glycated protein with the desired precision for clinical use [11] (Table 2) .
